Eureka Therapeutics Inc.

This early-stage trial tested a new treatment for advanced liver cancer. Doctors took a patient's own immune cells, modified them in a lab to better target cancer, and then put them back into the patient. The main goal was to find a safe dose, but the study was stopped early by t…